• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Exploring the experiences of cognitive symptoms in Long COVID: a mixed-methods study in the UK

tetano

Editor, Senior Moderator
BMJ Open


. 2025 Jan 25;15(1):e084999.
doi: 10.1136/bmjopen-2024-084999. Exploring the experiences of cognitive symptoms in Long COVID: a mixed-methods study in the UK

Amy Miller[SUP] 1 [/SUP], Ning Song[SUP] 2 [/SUP], Manoj Sivan[SUP] 2 [/SUP], Rumana Chowdhury[SUP] 3 [/SUP], Melanie Rose Burke[SUP] 2 [/SUP]



Affiliations
Free article Abstract

Objective: To explore the lived experiences and extent of cognitive symptoms in Long COVID (LC) in a UK-based sample.
Design: This study implemented a mixed-methods design. Eight focus groups were conducted to collect qualitative data, and the Framework Analysis was used to reveal the experiences and impact of cognitive symptoms. A self-report questionnaire was used to collect the quantitative data to assess the perceived change and extent of symptomology post COVID-19.
Setting: Focus groups were conducted in April 2023 online via Zoom and in-person at the University of Leeds, UK.
Participants: 25 people with LC living in the UK participated in the study. Participants were aged 19-76 years (M=43.6 years, SD=14.7) and included 17 women and 8 men.
Results: Reduced cognitive ability was among the most prevalent symptoms reported by the study participants. Three key themes were identified from the qualitative data: (1) rich accounts of cognitive symptoms; (2) the impact on physical function and psychological well-being and (3) symptom management. Descriptions of cognitive symptoms included impairments in memory, attention, language, executive function and processing speed. Cognitive symptoms had a profound impact on physical functioning and psychological well-being, including reduced ability to work and complete activities of daily living. Strategies used for symptom management varied in effectiveness.
Conclusion: Cognitive dysfunction in LC appears to be exacerbated by vicious cycle of withdrawal from daily life including loss of employment, physical inactivity and social isolation driving low mood, anxiety and poor cognitive functioning. Previous evidence has revealed the anatomical and physiological biomarkers in the brain affecting cognition in LC. To synthesise these contributing factors, we propose the Long-COVID Interacting Network of factors affecting Cognitive Symptoms. This framework is designed to inform clinicians and researchers to take a comprehensive approach towards LC rehabilitation, targeting the neural, individual and lifestyle factors.

Keywords: COVID-19; Cognition; PUBLIC HEALTH; QUALITATIVE RESEARCH.

 
Back
Top Bottom